https://www.selleckchem.com/pr....oducts/tefinostat.ht
Our findings suggest that PDOP is a promising platform for oncolytic immunotherapy.Mesenchymal stem cells (MSCs) have a tumor-homing ability-they accumulate inside tumors after systemic injection, and may thus be useful as carriers for tumor-targeting therapy. To use MSCs effectively as an anti-cancer therapy, they must first be functionalized with a large amount of anti-cancer drugs without causing any significant changes to their tumor-tropism. In the present study, we attempted to modify the cell surface of MSCs with doxorubicin-l
Giống
Bình luận
Đăng lại
